Skip to main content
NCBI home page
Signal Transduction and Targeted Therapy logoLink to Signal Transduction and Targeted Therapy
. 2021 Dec 20;6:432. doi: 10.1038/s41392-021-00794-y

Correction: AHR mediates the Aflatoxin B1 toxicity associated with hepatocellular carcinoma

Qing Zhu 1,#, Yarui Ma 1,#, Junbo Liang 2,#, Zhewen Wei 3,#, Mo Li 1, Ying Zhang 1, Mei Liu 1, Huan He 1, Chunfeng Qu 1, Jianqiang Cai 3, Xiaobing Wang 1,4,✉, Yixin Zeng 1,5,✉, Yuchen Jiao 1,4,6,✉
PMCID: PMC8685275  PMID: 34924560

Correction to: Signal Transduction and Targeted Therapy 10.1038/s41392-021-00713-1, published online 9 August 2021

After online publication of the article1, the authors noticed one inadvertent mistake occurred during the production process in Fig. 7 that needs to be corrected. The correct data are provided as follows. The key findings of the article are not affected by these corrections. The original article has been corrected.

Fig. 7.

Fig. 7

Open in a new tab

e Flow cytometry assessing the proportion of CD4/8+ cells with fluorescent antibodies against the cell markers indicated.

Footnotes

These authors contributed equally: Qing Zhu, Yarui Ma, Junbo Liang, Zhewen Wei

Contributor Information

Xiaobing Wang, Email: wangxb@cicams.ac.cn.

Yixin Zeng, Email: zengyx@sysucc.org.cn.

Yuchen Jiao, Email: jiaoyuchen@cicams.ac.cn.

References

  • 1.Zhu Q, et al. AHR mediates the Aflatoxin B1 toxicity associated with hepatocellular carcinoma. Signal Transduct. Target Ther. 2021;6:299. doi: 10.1038/s41392-021-00713-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Signal Transduction and Targeted Therapy are provided here courtesy of Nature Publishing Group

RESOURCES